These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3913459)

  • 1. Oral acyclovir in the suppression of recurrent non-genital herpes simplex virus infection.
    Meyrick Thomas RH; Dodd HJ; Yeo JM; Kirby JD
    Br J Dermatol; 1985 Dec; 113(6):731-5. PubMed ID: 3913459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status and prospects for oral acyclovir treatment of first episode and recurrent genital herpes simplex virus.
    Bryson YJ
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():61-5. PubMed ID: 6355052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects.
    Bryson YJ; Dillon M; Lovett M; Acuna G; Taylor S; Cherry JD; Johnson BL; Wiesmeier E; Growdon W; Creagh-Kirk T; Keeney R
    N Engl J Med; 1983 Apr; 308(16):916-21. PubMed ID: 6339923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent genital herpes suppressed by oral acyclovir: a multicentre double blind trial.
    Thin RN; Jeffries DJ; Taylor PK; Ayra OP; Rodin P; Yeo J; Fiddian AP
    J Antimicrob Chemother; 1985 Aug; 16(2):219-26. PubMed ID: 3905750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial.
    Peacock JE; Kaplowitz LG; Sparling PF; Durack DT; Gnann JW; Whitley RJ; Lovett M; Bryson YJ; Klein RJ; Friedman-Kien AE
    Am J Med; 1988 Sep; 85(3):301-6. PubMed ID: 3046350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial.
    Anderson H; Scarffe JH; Sutton RN; Hickmott E; Brigden D; Burke C
    Br J Cancer; 1984 Jul; 50(1):45-9. PubMed ID: 6378236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review.
    Sheffield JS; Hollier LM; Hill JB; Stuart GS; Wendel GD
    Obstet Gynecol; 2003 Dec; 102(6):1396-403. PubMed ID: 14662233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial.
    Rooney JF; Straus SE; Mannix ML; Wohlenberg CR; Alling DW; Dumois JA; Notkins AL
    Ann Intern Med; 1993 Feb; 118(4):268-72. PubMed ID: 8380540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.
    Patel R; Bodsworth NJ; Woolley P; Peters B; Vejlsgaard G; Saari S; Gibb A; Robinson J
    Genitourin Med; 1997 Apr; 73(2):105-9. PubMed ID: 9215091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections.
    Corey L; Benedetti JK; Critchlow CW; Remington MR; Winter CA; Fahnlander AL; Smith K; Salter DL; Keeney RE; Davis LG; Hintz MA; Connor JD; Holmes KK
    Am J Med; 1982 Jul; 73(1A):326-34. PubMed ID: 7048919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients.
    Shepp DH; Newton BA; Dandliker PS; Flournoy N; Meyers JD
    Ann Intern Med; 1985 Jun; 102(6):783-5. PubMed ID: 2986508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection.
    Mertz GJ; Critchlow CW; Benedetti J; Reichman RC; Dolin R; Connor J; Redfield DC; Savoia MC; Richman DD; Tyrrell DL
    JAMA; 1984 Sep; 252(9):1147-51. PubMed ID: 6088819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical acyclovir in the treatment of recurrent herpes simplex virus infections.
    Kinghorn GR
    Scand J Infect Dis Suppl; 1985; 47():58-62. PubMed ID: 3912972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral acyclovir suppressive therapy in severe recurrent genital herpes. A double-blind, placebo-controlled cross-over study.
    Kroon S; Petersen CS; Andersen LP; Rasmussen LP; Vestergaard BF
    Dan Med Bull; 1989 Jun; 36(3):298-300. PubMed ID: 2666040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes.
    Mattison HR; Reichman RC; Benedetti J; Bolgiano D; Davis LG; Bailey-Farchione A; Remington M; Winter C; Corey L
    Am J Med; 1988 Aug; 85(2A):20-5. PubMed ID: 3044086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyclovir suppression to prevent recurrent genital herpes at delivery.
    Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
    Infect Dis Obstet Gynecol; 2002; 10(2):71-7. PubMed ID: 12530483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy.
    Corey L; Benedetti J; Critchlow C; Mertz G; Douglas J; Fife K; Fahnlander A; Remington ML; Winter C; Dragavon J
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():79-88. PubMed ID: 6355054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily intravenous acyclovir for prophylaxis of herpes simplex virus reactivation after marrow transplantation.
    Shepp DH; Dandliker PS; Flournoy N; Meyers JD
    J Antimicrob Chemother; 1985 Sep; 16(3):389-95. PubMed ID: 2997101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection.
    Douglas JM; Critchlow C; Benedetti J; Mertz GJ; Connor JD; Hintz MA; Fahnlander A; Remington M; Winter C; Corey L
    N Engl J Med; 1984 Jun; 310(24):1551-6. PubMed ID: 6328298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.